Justin Walsh
Stock Analyst at B. Riley Securities
(3.47)
# 1,069
Out of 4,412 analysts
23
Total ratings
41.67%
Success rate
8.55%
Average return
Main Sectors:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $99 | $65.56 | +51.01% | 5 | Apr 18, 2024 | |
| ACHV Achieve Life Sciences | Initiates: Buy | $20 | $4.61 | +333.84% | 1 | Apr 17, 2024 | |
| FUSN Fusion Pharmaceuticals | Downgrades: Hold | n/a | $21.42 | - | 2 | Mar 20, 2024 | |
| CATX Perspective Therapeutics | Initiates: Buy | $1.4 | $1.58 | -11.39% | 1 | Nov 15, 2023 | |
| CTSO Cytosorbents | Reinstates: Buy | $4 | $0.82 | +388.40% | 2 | Sep 7, 2023 | |
| PRME Prime Medicine | Initiates: Buy | $20 | $4.43 | +351.98% | 1 | Sep 6, 2023 | |
| THTX Theratechnologies | Maintains: Buy | $24 → $12 | $1.31 | +816.03% | 1 | Jul 17, 2023 | |
| VOR Vor Biopharma | Initiates: Buy | $18 | $1.69 | +965.09% | 2 | May 16, 2023 | |
| TFFP TFF Pharmaceuticals | Initiates: Buy | $175 | $2.96 | +5,812.16% | 1 | Mar 22, 2023 | |
| MYNZ Mainz Biomed B.V. | Initiates: Buy | $11 | $0.82 | +1,244.58% | 1 | Feb 10, 2023 | |
| PSTV Plus Therapeutics | Initiates: Buy | $75 | $1.69 | +4,337.87% | 1 | Oct 7, 2022 | |
| HROW Harrow Health | Maintains: Buy | $17 → $20 | $10.53 | +89.93% | 1 | May 20, 2022 | |
| CRIS Curis | Maintains: Buy | $440 → $200 | $14.47 | +1,282.17% | 2 | Apr 5, 2022 | |
| CMPX Compass Therapeutics | Initiates: Buy | $10 | $1.45 | +589.66% | 1 | Jan 19, 2022 | |
| PRTG Portage Biotech | Initiates: Buy | n/a | $0.26 | - | 1 | Sep 2, 2021 |
Lantheus Holdings
Apr 18, 2024
Maintains: Buy
Price Target: $95 → $99
Current: $65.56
Upside: +51.01%
Achieve Life Sciences
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $4.61
Upside: +333.84%
Fusion Pharmaceuticals
Mar 20, 2024
Downgrades: Hold
Price Target: n/a
Current: $21.42
Upside: -
Perspective Therapeutics
Nov 15, 2023
Initiates: Buy
Price Target: $1.4
Current: $1.58
Upside: -11.39%
Cytosorbents
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.82
Upside: +388.40%
Prime Medicine
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $4.43
Upside: +351.98%
Theratechnologies
Jul 17, 2023
Maintains: Buy
Price Target: $24 → $12
Current: $1.31
Upside: +816.03%
Vor Biopharma
May 16, 2023
Initiates: Buy
Price Target: $18
Current: $1.69
Upside: +965.09%
TFF Pharmaceuticals
Mar 22, 2023
Initiates: Buy
Price Target: $175
Current: $2.96
Upside: +5,812.16%
Mainz Biomed B.V.
Feb 10, 2023
Initiates: Buy
Price Target: $11
Current: $0.82
Upside: +1,244.58%
Plus Therapeutics
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $1.69
Upside: +4,337.87%
Harrow Health
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $10.53
Upside: +89.93%
Curis
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $14.47
Upside: +1,282.17%
Compass Therapeutics
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Portage Biotech
Sep 2, 2021
Initiates: Buy
Price Target: n/a
Current: $0.26
Upside: -